Another California Lawsuit Alleges That a Cannabis Company Exaggerated THC Levels of Products
Complete the form below and we will email you a PDF version of "Another California Lawsuit Alleges That a Cannabis Company Exaggerated THC Levels of Products"
Two California-based cannabis companies have been accused of inflating the THC levels of their products.
In a class action lawsuit filed on October 28, seen by Analytical Cannabis, a plaintiff alleges that pre-rolls sold by the companies Greenfield Organix and LPF JV Corporation contain less THC than advertised.
The lawsuit follows another, filed by the same lawyers on October 20, that claimed another company, DreamFields Brands, had exaggerated the levels of THC on the packaging of its pre-rolls.
Into the lawsuit
According to the lawsuit, Greenfield’s King Roll pre-roll products first came under suspicion in September following an independent lab test of several Californian pre-roll brands.
This investigation was carried out at the behest of Weed Week, which published an article on its findings on September 8.
The test results found that the King Roll Master Kush x Cannalope Kush Infused 4-Pack pre-roll had a THC content between 33 and 36%. This range is substantially lower than the product’s advertised THC content, 47%.
The plaintiff in the suit is said to have purchased a King Roll product in March at a “premium” price, one that was justified by the purported high THC levels.
“Plaintiff and the class therefore sustained an economic injury and paid a price premium as a result of Defendants’ false and misleading labels,” the lawsuit writes.
The plaintiff seeks damages, equitable relief, attorney’s fees, and an injunction.
Analytical Cannabis has reached out to LPF JV Corporation, also known as Loudpack, for comment.
The suit was filed by Christin Cho and Simon Franzini of Dovel & Luner, LLP, the same law firm that filed the recent lawsuit against DreamFields Brands.
The problem of THC inflation
As the lawsuit notes, THC inflation is a common issue within the legal cannabis sector. Given the demand for high-THC products, many cannabis companies are known to “shop” their products around different cannabis labs until they find one that reports high enough THC levels. Any lab that reports the true, lower amount of THC doesn’t get the contract.
The practice is called lab shopping, and it’s a blight on the cannabis testing sector.
“We still see this today with lab shopping – customers, in some cases, seeking results to be guaranteed,” Jeff Journey, CEO of SC Labs, told Analytical Cannabis in July.
“And there are ramifications for that in the long term. At least for SC labs, we will always comply with our methods that are approved; we will not bow to market pressures to compromise at all. And that might hurt us in the short term. It does; we lose business. I think that’s just the reality of our market today.”
“But I think, in the long term, our belief is that the good guys will win, those that are ethical, those that can be trusted with results, that are consistent with the methods that they have approved.”